Echo Therapeutics Inc. (ECTE.OB) Contributes Enormous Healthcare Business Value
Regulatory approval marks a major milestone for investors exploring the business environment for exceptional stock opportunities in the healthcare sector. Individuals and teams get brilliant ideas all the time, but only a tiny fraction of them make it past the eagle eyes of the US Food and Drug Administration (FDA). Here is a loss-making company with a novel technology that has passed all the stringent and exhaustive steps towards FDA approval. The FDA does not consider economics, so investors must normally contend with the risk of infeasible selling prices or inadequate margins when buying stock on the basis of regulatory…
